Drug Safety Monitoring

The pharmaceutical science pertaining to the "collection, identification, assessment, monitoring, and prevention" of adverse effects with pharmaceutical goods is known as Pharmacovigilance (PV, or PhV), also known as Drug Safety. The words "pharmacovigilance" and "pharmakon," both from the Greek for "drug," have similar etymological roots (Latin for to keep watch). As a result, pharmacovigilance places a lot of emphasis on Adverse Drug Reactions (ADR), which are described as any noxious and unintended response to a drug, such as a lack of efficacy (the condition that this definition only applies with the doses normally used for the prophylaxis, diagnosis or therapy of disease, or for the modification of physiological disorder function was excluded with the latest amendment of the applicable legislation). Even in the absence of an adverse event, medication mistakes such as overdosing, drug addiction, misuse, and exposure to drugs while pregnant or nursing are of importance since, they may result in a negative pharmacological reaction. The data required for pharmacovigilance are provided through information obtained from patients and healthcare professionals via pharmacovigilance agreements, as well as from other sources including the medical literature. Most nations require the licence holder (often a pharmaceutical corporation) to provide adverse event data to the local drug regulatory body in order to market or test a pharmaceutical product.